Stock Groups

Chinese biotech company BeiGene opens lower on Shanghai debut -Breaking

[ad_1]

© Reuters.

BEIJING (Reuters), a Chinese biotech firm BeiGene (NASDAQ:) Ltd closed lower in Shanghai on Wednesday, after it raised over $3Billion through the largest STAR Market listing of this year.

BeiGene’s opening price was 176.96yuan (8.1% below its 192.6yuan offer price).

Disclaimer: Fusion MediaThis website does not provide accurate and current data. CFDs include stocks, futures, indexes and Forex. Prices are provided not by the exchanges. Market makers provide them. Therefore, prices can be inaccurate and differ from actual market prices. These prices should not be used for trading. Fusion Media does not accept any liability for trade losses you may incur due to the use of these data.

Fusion MediaFusion Media or any other person involved in the website will not be held responsible for any loss or damage resulting from reliance on this information, including charts, buy/sell signals, and data. Trading the financial markets is one of most risky investment options. Please make sure you are fully aware about the costs and risks involved.

[ad_2]